Actualités réglementaires24 août 2026•1 min de lecture

FDA Recalls Product Due to CGMP Deviations

Par l'équipe PharmaCountry

The FDA has initiated a recall of a product because of deviations from current Good Manufacturing Practices (CGMP).

The U.S. Food and Drug Administration (FDA) has issued a recall for a pharmaceutical product after identifying deviations from current Good Manufacturing Practices (CGMP). The recall underscores the agency's focus on ensuring manufacturing compliance and product safety.

Compilé par l'équipe PharmaCountry · Source : FDA.gov

Sujets :#FDA #recall #CGMP #regulatory #pharmaceuticals